To elucidate the cytoprotective mechanisms of CGA against hepatic inflammation induced by chronic stress, this study utilized the JAK2/STAT3 pathway inhibitor S3I-201 for targeted intervention in the cohort subjected to the CRS group. The gene discussed is STAT3; the disease is congenital rubella syndrome.